"Ready to Sail 2 - EXTEND" is a pilot randomized interventional trial designed to assess the feasibility, safety, and preliminary impact of an innovative rehabilitation model combining sailing therapy (velatherapy) with a remote telerehabilitation maintenance program in young individuals with rare skeletal disorders. Building on the promising results of the previous Ready to Sail feasibility study (NCT06397443), this study aims to validate and compare two rehabilitative approaches. A total of 24 patients aged 12-30 years with a confirmed diagnosis of a rare skeletal disorder will be randomly assigned (1:1) to either: * Group 1 (Experimental): a 5-day intensive sailing therapy intervention followed by a 3-month personalized telerehabilitation program at home; or * Group 2 (Active Control): a 3-month telerehabilitation-only program with identical frequency and progression. The primary objective is to evaluate the feasibility of the experimental program, in terms of adherence, acceptability, and safety. Secondary outcomes include motor functionality (measured by inertial sensors), psychosocial well-being (assessed through validated PROMs), health-related quality of life, and pain perception. The study also explores the medium-term sustainability of rehabilitation outcomes and the influence of individual variables (e.g., age, gender, disease subtype). The intervention is delivered through a multidisciplinary, patient-centered approach involving rare disease experts, physiatrists, biomechanical engineers, and partner sailing organizations. Sail training activities are adapted for safety and inclusion, and are conducted in two coastal settings (Marina di Ravenna and Palermo), ensuring geographical balance for participant accessibility. This trial seeks to strengthen the evidence base for integrated, inclusive, and scalable rehabilitation models that address both motor and psychosocial dimensions in rare skeletal conditions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
24
A two-phase rehabilitation program combining 5 days of intensive sailing therapy with a 3-month home-based telerehabilitation plan. The sailing component includes group-based activities in adapted sailing environments, conducted in Marina di Ravenna or Palermo, with daily debriefing and psychosocial support. The telerehabilitation component includes twice-weekly supervised sessions delivered via a digital platform, focusing on progressive motor, proprioceptive, and postural exercises. The intervention aims to improve motor function, quality of life, and psychosocial well-being in individuals with rare skeletal disorders.
Participants perform a 3-month home-based rehabilitation program consisting of two remote sessions per week via a supervised digital platform. Each session includes warm-up, strength and coordination exercises, and cool-down. Exercises are progressive and standardized, but adapted to individual needs to ensure safety and adherence. The intervention targets motor function, balance, proprioception, and psychosocial outcomes, without any sailing component. This arm serves as the active comparator.
IRCCS Istituto Ortopedico Rizzoli
Bologna, Italy
RECRUITINGAdherence to Sailing and Home-Based Telerehabilitation
Defined as the percentage of scheduled sessions completed by each participant. Adherence is considered achieved if ≥75% of scheduled sessions are completed. Unit of Measure: Percentage of participants meeting adherence threshold
Time frame: At 6 months after baseline (end of intervention period)
Acceptability of the Intervention
Defined by recruitment rate ≥80% and dropout rate \<20%. Unit of Measure: Recruitment rate (%), Dropout rate (%)
Time frame: At 6 months after baseline (end of intervention period)
Safety of the Intervention
Defined as the absence of serious adverse events related to the intervention. Unit of Measure: Number of participants experiencing a serious adverse event
Time frame: At 6 months after baseline (end of intervention period)
Change in Motor Function Measured by Inertial Measurement Units
Motor function will be assessed using wearable inertial measurement units (IMUs) to evaluate postural control, gait parameters, upper limb mobility, and proprioception. Data will be collected through standardized physical tasks and analyzed to detect changes over time.
Time frame: Baseline (T0), up to 1-day after intervention (T1-only for experimental arm), and at 3-Month Follow-Up (T2)
Change in Health-Related Quality of Life Measured by EQ-5D-5L
Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. This instrument includes: 1. EQ-5D-5L Index Value, ranging from -0.232 to 1.000 (where 1.000 indicates full health, 0 indicates death-equivalent health, and negative values represent health states considered worse than death; higher scores indicate better health status). 2. EQ Visual Analog Scale (EQ-VAS), ranging from 0 to 100, where 0 represents the "worst imaginable health state" and 100 represents the "best imaginable health state." Higher scores indicate better self-rated health. Unit of Measure: EQ-5D-5L Index Value (-0.281 to 1.000); EQ-VAS Score (0 to 100)
Time frame: Baseline (T0), up to 1-day after intervention (T1-only for experimental arm), and at 3-Month Follow-Up (T2)
Change in Psychosocial Functioning Measured by BESSI-45
Psychosocial functioning will be assessed using the Behavioral, Emotional, and Social Skills Inventory (BESSI-45). The BESSI-45 includes 45 items rated on a 5-point Likert scale (1 = "Not at all well" to 5 = "Extremely well"), covering five domains: Self-Management, Social Engagement, Cooperation, Emotional Resilience, and Innovation Skills. Total scores range from 45 to 225, with higher scores reflecting greater psychosocial skills and better psychosocial functioning. Unit of Measure: BESSI-45 total score (range 45-225)
Time frame: Baseline (T0), up to 1-day after intervention (T1-only for experimental arm), and at 3-Month Follow-Up (T2)
Change in Functional Outcomes Measured by PODCI
Functional health outcomes will be assessed using the Pediatric Outcomes Data Collection Instrument (PODCI), which includes domains such as upper extremity function, mobility, sports and physical activity, pain, happiness, and global function.
Time frame: Baseline (T0), up to 1-day after intervention (T1-only for experimental arm), and at 3-Month Follow-Up (T2)
Change in Pain Intensity Measured by Visual Analogue Scale (VAS)
Pain intensity will be assessed using the Visual Analogue Scale for Pain (VAS-Pain), a 10-centimeter horizontal line anchored at the extremes with "0 = no pain" and "10 = worst pain imaginable." Participants mark their current pain level along the line, which is then measured in centimeters from the "no pain" anchor. Scores range from 0 to 10, with higher scores indicating greater pain intensity. Unit of Measure: VAS-Pain score (0-10)
Time frame: Baseline (T0), up to 1-day after intervention (T1-only for experimental arm), and at 3-Month Follow-Up (T2)
Change in Kinesiophobia Measured by Tampa Scale of Kinesiophobia (TSK)
Fear of movement will be assessed using the Tampa Scale of Kinesiophobia - 13-item version (TSK-13). The TSK-13 includes 13 items rated on a 4-point Likert scale ranging from 1 ("strongly disagree") to 4 ("strongly agree"). Total scores range from 13 to 52, with higher scores indicating greater fear of movement and higher levels of kinesiophobia. Unit of Measure: TSK-13 total score (range 13-52)
Time frame: Baseline (T0), up to 1-day after intervention (T1-only for experimental arm), and at 3-Month Follow-Up (T2)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.